Ovid Therapeutics
OVID
OVID
82 hedge funds and large institutions have $64.4M invested in Ovid Therapeutics in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 40 increasing their positions, 14 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
55% less capital invested
Capital invested by funds: $144M → $64.4M (-$79.5M)
71% less call options, than puts
Call options by funds: $205K | Put options by funds: $703K
Holders
82
Holding in Top 10
–
Calls
$205K
Puts
$703K
Top Buyers
| 1 | +$2.08M | |
| 2 | +$1.64M | |
| 3 | +$1.51M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.34M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.18M |
Top Sellers
| 1 | -$9.81M | |
| 2 | -$6.3M | |
| 3 | -$1.29M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$779K |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$695K |